NOTCH1 and small cell lung carcinoma: Additionally, SCLC patients with positive Delta‐like 3 expression, which belongs to the Notch ligand family and had no mutation in Notch1, exhibited higher PD‐L1 expression and may be more likely to benefit from PD‐1/PD‐L1 ICI treatment [24].